Publications

Detailed Information

OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells

DC Field Value Language
dc.contributor.authorKim, Mi-Jung-
dc.contributor.authorNam, Hyun-Jin-
dc.contributor.authorKim, Hwang-Phill-
dc.contributor.authorHan, Sae-Won-
dc.contributor.authorIm, Seock-Ah-
dc.contributor.authorKim, Tae-You-
dc.contributor.authorOh, Do-Youn-
dc.contributor.authorBang, Yung-Jue-
dc.date.accessioned2021-01-31T11:12:08Z-
dc.date.available2021-01-31T11:12:08Z-
dc.date.created2020-12-21-
dc.date.created2020-12-21-
dc.date.created2020-12-21-
dc.date.created2020-12-21-
dc.date.issued2013-07-
dc.identifier.citationCancer Letters, Vol.335 No.1, pp.145-152-
dc.identifier.issn0304-3835-
dc.identifier.other119340-
dc.identifier.urihttps://hdl.handle.net/10371/173104-
dc.description.abstractWe investigated the mechanisms of action and antitumor effects of OPB-31121, a novel STAT3 inhibitor, in gastric cancer cells. OPB-31121 downregulated JAK2 and gp130 expression and inhibited JAK2 phosphorylation which leads to inhibition of STAT3 phosphorylation. OPB-31121 inhibited constitutively activated and IL-6-induced JAK/STAT signaling pathway. OPB-31121 decreased cell proliferation in both gastric cancer cells and in a xenograft model, induced the apoptosis of gastric cancer cells, inhibited the expression of antiapoptotic proteins, and showed synergism with 5-fluorouracil and cisplatin. Taken together, our study suggests that STAT3 inhibition with OPB-31121 can be tested in patients with gastric cancer. (c) 2013 Elsevier Ireland Ltd. All rights reserved.-
dc.language영어-
dc.publisherElsevier BV-
dc.titleOPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells-
dc.typeArticle-
dc.contributor.AlternativeAuthor임석아-
dc.identifier.doi10.1016/j.canlet.2013.02.010-
dc.citation.journaltitleCancer Letters-
dc.identifier.wosid000323853200018-
dc.identifier.scopusid2-s2.0-84878432714-
dc.citation.endpage152-
dc.citation.number1-
dc.citation.startpage145-
dc.citation.volume335-
dc.identifier.sci000323853200018-
dc.description.isOpenAccessN-
dc.contributor.affiliatedAuthorIm, Seock-Ah-
dc.contributor.affiliatedAuthorKim, Tae-You-
dc.contributor.affiliatedAuthorOh, Do-Youn-
dc.contributor.affiliatedAuthorBang, Yung-Jue-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.subject.keywordPlusACTIVATED SIGNAL TRANSDUCER-
dc.subject.keywordPlusHUMAN MYELOMA CELLS-
dc.subject.keywordPlusCONSTITUTIVE ACTIVATION-
dc.subject.keywordPlusCONFERS RESISTANCE-
dc.subject.keywordPlusKINASE INHIBITOR-
dc.subject.keywordPlusSTAT3 ACTIVATION-
dc.subject.keywordPlusEXPRESSION-
dc.subject.keywordPlusAPOPTOSIS-
dc.subject.keywordPlusTRANSCRIPTION-3-
dc.subject.keywordPlusGP130-
dc.subject.keywordAuthorOPB-31121-
dc.subject.keywordAuthorGastric cancer-
dc.subject.keywordAuthorSTAT3-
dc.subject.keywordAuthorJAK2-
dc.subject.keywordAuthorIL-6-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area Clinical Medicine

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share